Utah Symphony

Biotech Entrepreneur and Venture Capitalist Dinesh Patel Discusses Therapeutics and Medical Devices with CancerVAX CEO Ryan Davies

Retrieved on: 
Wednesday, May 17, 2023

Dr. Patel founded TheraTech, a biotech company he took public and later sold to Watson Pharmaceuticals (now Abbvie).

Key Points: 
  • Dr. Patel founded TheraTech, a biotech company he took public and later sold to Watson Pharmaceuticals (now Abbvie).
  • He then founded Salus Therapeutics, a biotech company focused on nucleic acid-based therapeutics, including gene therapy drugs and also founded Ashni Natraceuticals.
  • Dr. Patel was a founding partner of v-Spring Capital, a Utah-based venture capital firm active in biotech and high-tech sectors.
  • I’ve known and admired him as an investor and biotech entrepreneur for many years,” said Ryan Davies, CancerVAX CEO.

KMFA Launches New Program

Retrieved on: 
Monday, February 21, 2022

AUSTIN, Texas, Feb. 21, 2022 /PRNewswire/ -- KMFA Classical 89.5 announces launch of the Draylen Mason Composer-in-Residence program with Dallas-based, rising composer Quinn Mason named as the inaugural commissioned composer.

Key Points: 
  • AUSTIN, Texas, Feb. 21, 2022 /PRNewswire/ -- KMFA Classical 89.5 announces launch of the Draylen Mason Composer-in-Residence program with Dallas-based, rising composer Quinn Mason named as the inaugural commissioned composer.
  • Mason will spend the week of February 21-25 in residence with KMFA in Austin, Texas.
  • The Draylen Mason Composer-in-Residence program was inspired by the national call for greater diversity in classical music.
  • "KMFA strives to bring our listeners a diverse range of music, including works by the underrepresented, including women and composers of color," explains KMFA Director of Broadcasting & Content Anthony McSpadden, who conceived the program.